Discovery could increase efficacy of promising cystic fibrosis drug
Thursday, March 21, 2013 - 15:00
in Health & Medicine
Researchers believe they have found exactly how Kalydeco (Vx-770), the first drug of its kind to treat the underlying cause of cystic fibrosis, works and how to improve its effectiveness in the future.